Novartis Plans OTC Market Assault

January 2007 | Product Launch

Swiss drugmaker Novartis has launched its consumer healthcare division in Japan and it is planning to become a top 10 player within the next five years. Given the company's diversified portfolio of products for prevalent conditions coupled with its increasing focus on the Japanese market, BMI is fairly confident that Novartis will achieve its aim of penetrating the over-the-counter (OTC)

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.